BRAF and colorectal carcinoma: A study of almost 10,000 metastatic CRC that were sequenced with MSK-IMPACT showed that non-V600 BRAF mutations occurred in 2.2% of cases, the vast majority being found in MSS cancers, and accounted for 22% of all BRAF mutations [23].